Browsing by Author "Okello, Iginitius"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
    (In Open forum infectious diseases, 2021) Ssengooba, Willy; Iragena, Jean de Dieu; Komakech, Kevin; Okello, Iginitius; Nalunjogi, Joanitah; Katagira, Winceslaus; Kimuli, Ivan; Adakun, Susan; Joloba, Moses L.; Torrea, Gabriela; Kirenga, Bruce J.
    The Global Laboratory Initiative (GLI) guidelines recommend repeat for GeneXpertMTB/RIF (XpertMTB/RIF) in patients with a low pretest probability of rifampicin resistance (RR). This was a cross-sectional study using results of sputum specimens collected from participants screened for the STREAM 2 trial. We recruited all patients with XpertMTB/RIF RR-TB detected who were referred for RR/multidrug-resistant (MDR) TB treatment initiation at Mulago National Referral Hospital, Kampala, between September 2017 and October 2019. At baseline, smear microscopy, repeat XpertMTB/RIF, Xpert Ultra, and MTBDRplus assays were done on sputum specimens. Culturebased drug susceptibility testing (DST) was performed on discordant specimens. We analyzed the prevalence and factors associated with discordance between initial and repeat XpertMTB/RIF RR and false XpertMTB/RIF RR. False XpertMTB/RIF RR was defined as no RR detected by any of Xpert Ultra, LPA, or culture DST (reference comparator).